• Repositorio Institucional Universidad de Pamplona
  • Trabajos de pregrado y especialización
  • Facultad de Salud
  • Medicina
    • Por favor, use este identificador para citar o enlazar este ítem: http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/1095
    Registro completo de metadatos
    Campo DC Valor Lengua/Idioma
    dc.contributor.authorCordero Sanchez, Daniela.-
    dc.contributor.authorMoreno Hernandez, Everth Andrés.-
    dc.date.accessioned2022-05-25T15:21:00Z-
    dc.date.available2018-01-23-
    dc.date.available2022-05-25T15:21:00Z-
    dc.date.issued2018-
    dc.identifier.citationCordero Sánchez, D.; Moreno Hernández, E. A. (2017). Incidencia, manejo y evolución de los pacientes con trombocitopenia primaria inmune tratados en la E.S.E. Hospital Universitario Erasmo Meoz durante el periodo 2014– 2016 [Trabajo de Grado Pregrado, Universidad de Pamplona]. Repositorio Hulago Universidad de Pamplona. http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/1095es_CO
    dc.identifier.urihttp://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/1095-
    dc.descriptionLos autores no proporciona la información sobre este ítem.es_CO
    dc.description.abstractLos autores no proporciona la información sobre este ítem.es_CO
    dc.format.extent46es_CO
    dc.format.mimetypeapplication/pdfes_CO
    dc.language.isoeses_CO
    dc.publisherUniversidad de Pamplona – Facultad de Salud.es_CO
    dc.subjectTratamiento de erradicación.es_CO
    dc.subjectHelicobacter Pylori.es_CO
    dc.subjectRecuento de plaquetas.es_CO
    dc.subjectPúrpura.es_CO
    dc.subjectTrombocitopénica Idiopática.es_CO
    dc.subjectPeliosis Hepática.es_CO
    dc.subjectHepatomegalia.es_CO
    dc.subjectEsteroides.es_CO
    dc.subjectFranciaes_CO
    dc.subjectTrombocitopenia Primaria Inmune.es_CO
    dc.subjectEpidemiologia.es_CO
    dc.subjectIncidencia.es_CO
    dc.subjectIvig.es_CO
    dc.subjectNiños.es_CO
    dc.subjectTpi.es_CO
    dc.subjectSalud relacionada con la calidad de vida.es_CO
    dc.subjectIncidencia (2009).es_CO
    dc.titleIncidencia, manejo y evolución de los pacientes con trombocitopenia primaria inmune tratados en la E.S.E. Hospital Universitario Erasmo Meoz durante el periodo 2014 – 2016.es_CO
    dc.typehttp://purl.org/coar/resource_type/c_7a1fes_CO
    dc.date.accepted2017-10-23-
    dc.relation.references1. https://es.scribd.com/document/354667417/7)es_CO
    dc.relation.references2. Michel, M. (2009), Immune thrombocytopenic purpura: epidemiology and implications for patients. European Journal of Haematology, 82: 3–7. doi: 10.1111/j.16000609.2008.01206.xes_CO
    dc.relation.references3. http://www.medigraphic.com/pdfs/imss/im-2014/im143q.pdfes_CO
    dc.relation.references4. https://demedicina.com/corticoides-efectos-secundarios/es_CO
    dc.relation.references5. http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=ES&Expert=3002es_CO
    dc.relation.references6. Leo C.A., Pravisani R., Bidinost S., Baccarani U., Bresadola V., Risaliti A., Terrosu G. Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen G Chir Vol. 36 - n. 4 - pp. 153-157 JulyAugust 2015es_CO
    dc.relation.references7. Kim, S. B., Kim, D. K., Byun, S. J., Park, J. H., Choi, J. Y., Park, Y. N., & Kim, D. Y. (2015). Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura. Clinical and Molecular Hepatology, 21(4), 387–392. http://doi.org/10.3350/cmh.2015.21.4.387es_CO
    dc.relation.references8. Hwang, J. J., Lee, D. H., Yoon, H., Shin, C. M., Park, Y. S., & Kim, N. (2016). The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura. Gut and Liver, 10(3), 356–361. http://doi.org/10.5009/gnl14483es_CO
    dc.relation.references9. Hsiao, C.-H., Tseng, K.-C., Tseng, C.-W., & Tung, C.-H. (2015). Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report. Medicine, 94(34), e1296. http://doi.org/10.1097/MD.0000000000001296es_CO
    dc.relation.references10. W.-J. Dai, R.-R. Zhang, X.-C. Yang, Y.-F. Yuan Efficacy of standard dose rituximab for refractory idiopathic thrombocytopenic purpura in children. Eur Rev Med Pharmacol Sci 2015; 19 (13): 2379-2383es_CO
    dc.relation.references11. Moulis G, Palmaro A, Montastruc J, Godeau B, Lapeyre-Mestre M and Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood Journal 2014, Novemeber 20es_CO
    dc.relation.references12. Emilia Parodi, Paola Giordano, Elisa Rivetti, Maria Teresa Giraudo, Giulia Ansaldi, Mirella Davitto, Anna Mondino, Piero Farruggia, Giovanni Amendola, Sofia M.R. Matarese, Francesca Rossi, Giovanna Russo, Ugo Ramenghi. Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptoms. Blood Transfus 2014; 12: 340-5es_CO
    dc.relation.references13. http://www.medigraphic.com/pdfs/hematologia/re-2016/re164f.pdfes_CO
    dc.relation.references14. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951 Jul;38(1):1-10.es_CO
    dc.relation.references15. Shulman NR, Marder VJ, Weinrach RS. Similarities between know antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci. 1965 Jun 30;124(2):499542es_CO
    dc.relation.references16. van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE. Specificity of autoantiboides in autoimmune thrombocytopenia. Blood. 192 Jan;59(1):23-6es_CO
    dc.relation.references17. Sukati H, Watson HG, Urbaniak SJ, Barket RN. Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood. 2007 May 15; 109(10):4528-38es_CO
    dc.relation.references18. McMillan R, Wang L, Tani P. Prospective evaluation of the immunobed assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Hemost. 2003 Mar;1(3):485-91es_CO
    dc.relation.references19. Brighton Ta, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood. 1996 Jul 1;88(1):194-201es_CO
    dc.relation.references20. Stockerlberg D, Hou M, Jacobsson S, Kutti J, Wadenvik H. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen captura ELISA. Eur J Haematol. 1996 Jan-Feb;56(1-2):72-7.es_CO
    dc.relation.references21. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kwakami Y, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cell in patients with immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest. 1998 Oct 1;102(7):1393-402es_CO
    dc.relation.references22. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cell in patients with immune thrombocytopenic purpura. Blood. 2001 Jul 1;98(1):130-9.es_CO
    dc.relation.references23. Primer capítulo del libro (anexo fotos)es_CO
    dc.relation.references24. http://www.medigraphic.com/pdfs/residente/rr-2015/rr153f.pdfes_CO
    dc.relation.references25. Segundo capítulo del libro (anexo fotos)es_CO
    dc.relation.references26. Stasi R; Willis F, Shannon Ms, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009 Dec;23(6):1275-97.es_CO
    dc.relation.references27. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for antiplatelet GPIIIa of HIV-1 related immunologic thrombocytopenia. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7589-94es_CO
    dc.relation.references28. Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1 related immunologic thrombocytopenia. Blood. 2005 Jul 15;106(2):572-6.es_CO
    dc.relation.references29. Zhang W, Nardi MA, BOrkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatisis C-related immunologic thrombocytopenia. Blood. 2009 Apr 23;113(17):4086-93es_CO
    dc.relation.references30. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pyloriassociated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004 Jan;124(1):142-9.es_CO
    dc.relation.references31. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009 Feb 5;113(6):1231-40.es_CO
    dc.relation.references32. http://www.medigraphic.com/pdfs/hematologia/re-2016/re164f.pdfes_CO
    dc.relation.references33. tercer capitulo del libro: The diagnosis and management of chronic immune thrombocytopenia in adults (anexo fotos)es_CO
    dc.relation.references34. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood. 2009;113:6511-21.es_CO
    dc.relation.references35. Cines DB, Liebman H; Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-14.es_CO
    dc.relation.references36. Cines DB. Pathogensis of ITP. In Cines DB, Kuter DJ, Newland AC, Povan D, Semple, JW, editors, Immune Thrombocytopenia: The Handbook. 2011ESH Forum Service Editore. P. 77-89es_CO
    dc.relation.references37. http://www.medigraphic.com/pdfs/residente/rr-2015/rr153f.pdfes_CO
    dc.relation.references38. Provan D, Newland AC, et al. British Committee for Standars in Haematology, General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574-96.es_CO
    dc.relation.references39. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40es_CO
    dc.relation.references40. Mazzucconi NG, Fazi P, Bernasconi S, et al. Therapy with high-dose dexamethasone (HDDXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura. A GIMEMA experience. Blood. 2007;109:1401-7.es_CO
    dc.relation.references41. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549-54.es_CO
    dc.relation.references42. Stasi R, Stipa E, Masi M, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436-42.es_CO
    dc.relation.references43. http://www.bloodjournal.org/content/117/16/4190?sso-checked=truees_CO
    dc.relation.references44. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623-34.es_CO
    dc.relation.references45. Wanachiwanawin W, Visudhiphan S, pinankijagum A, Vatanavicharn S. Therapy of chronic idiopathic thrombocytopenic purpura in adult: Experiences from Thailand. Southeast Asian J Trop Med Public Health. 1993;24(Suppl 1):71-5.es_CO
    dc.relation.references46. Robinette CD, Fraumeni JF. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet .1977;ii:127-9.es_CO
    dc.relation.references47. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43:182-6.es_CO
    dc.relation.references48. Schwartz J, Leber MD, Gilis S, et al. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003;72:94-8.es_CO
    dc.relation.references49. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppresion of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364-1369.es_CO
    dc.relation.references50. Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-4.es_CO
    dc.relation.references51. Yu J, Heck S, Patel V, et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood. 2008;112:1325-8.es_CO
    dc.relation.references52. https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000200008es_CO
    dc.relation.references53. http://www.medigraphic.com/pdfs/hematologia/re-2010/re102g.pdfes_CO
    dc.relation.references54. https://www.pediatriaintegral.es/numeros-anteriores/publicacion-2012-06/interpretaciondel-hemograma/es_CO
    dc.relation.references55. http://www.who.int/vmnis/indicators/haemoglobin_es.pdfes_CO
    dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2es_CO
    dc.type.coarversionhttp://purl.org/coar/resource_type/c_2df8fbb1es_CO
    Aparece en las colecciones: Medicina

    Ficheros en este ítem:
    Fichero Descripción Tamaño Formato  
    Cordero_Moreno_2017_TG.pdfCordero_Moreno_2017_TG785,56 kBAdobe PDFVisualizar/Abrir
    Mostrar el registro sencillo del ítem


    Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.